Related Experiment Video

Updated: Apr 24, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.1K

The landscape of kinase fusions in cancer

Nicolas Stransky1, Ethan Cerami1, Stefanie Schalm1

  • 1Blueprint Medicines, Cambridge, Massachusetts 02142, USA.

Nature Communications
|September 11, 2014
PubMed

Insights

Researchers developed a new method to detect gene fusions in cancer using RNA sequencing data. This analysis of thousands of cancer genomes revealed novel kinase fusions, expanding therapeutic options for patients.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Human cancer genomes exhibit diverse alterations affecting critical cellular pathways.
  • While mutations, deletions, and amplifications are well-studied, gene fusions remain less characterized.
  • Understanding these alterations is crucial for targeted cancer therapies.

Purpose of the Study:

  • To develop reliable heuristics for detecting gene fusion events in RNA sequencing (RNA-seq) data.
  • To comprehensively characterize gene fusions across a large cohort of human cancer samples.
  • To identify novel gene fusions with potential clinical implications.

Main Methods:

  • Development of novel computational heuristics for gene fusion detection.
  • Application of these methods to nearly 7,000 cancer samples from The Cancer Genome Atlas (TCGA).
  • Analysis of RNA-sequencing data to identify fusion events.

Main Results:

  • Successfully identified several novel and recurrent gene fusions.
  • Discovered fusions specifically involving kinases, key regulators of cellular signaling.
  • The identified fusions were found across a significant number of cancer samples.

Conclusions:

  • The developed heuristics provide a reliable method for gene fusion detection in cancer genomics.
  • The discovery of novel kinase fusions expands the landscape of actionable targets in cancer.
  • These findings have direct clinical relevance, potentially offering new therapeutic strategies for cancer patients.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.1K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.5K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K